Announcements Trials
Browse Landscape

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Lung Neoplasms 4Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Depression 2Vulvar Neoplasms 1Vomiting 1Stomach Neoplasms 1Patient Compliance 1Pancreatic Neoplasms 1Non-resectable Metastatic Cancer of the Lung 1Neuroblastoma 1Nausea 1Leukemia 1Laryngeal Diseases 1Hematologic Neoplasms 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Anxiety Disorders 1Anus Neoplasms 1

Interventions

Capecitabine 27pembrolizumab 19Oxaliplatin 19Fluorouracil 17Cisplatin 17Trastuzumab 14Docetaxel 14Leucovorin 11Paclitaxel 8Irinotecan 8S 1 (combination) 7Epirubicin 6Cyclophosphamide 5tegafur-gimeracil-oteracil 4aldesleukin 4Hyperthermic Intraperitoneal Chemotherapy 4titanium silicide 3spartalizumab 3fludarabine phosphate 3fludarabine 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Ramucirumab 3Nivolumab 3Indocyanine Green 3Gemcitabine 3Carboplatin 3Albumin-Bound Paclitaxel 3Ado-Trastuzumab Emtansine 3vistusertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Stomach Neoplasms × Interviews as Topic × Clear all
NCT00394602 2020-01-02

Chemoradiation-Induced Nausea and Emesis: Quality of Life

M.D. Anderson Cancer Center

Terminated
207 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Nausea, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡